Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial

Oncotarget - United States
doi 10.18632/oncotarget.8226
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer

Annals of Coloproctology
Gastroenterology
2019English

Lapatinib-Capecitabine Versus Capecitabine Alone as Radiosensitizers in RAS Wild-Type Resectable Rectal Cancer, an Adaptive Randomized Phase II Trial (LaRRC Trial): Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2016English

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

Lapatinib Plus Capecitabine in Women With HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial

Oncologist
Cancer ResearchMedicineOncology
2010English

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Postoperative Radiation Therapy for Rectal Cancer: An Interim Analysis of a Prospective, Randomized Multicenter Trial in the Netherlands

Cancer
Cancer ResearchOncology
1992English

2318 Prospective Phase II Trial of Pazopanib Plus CapeOX (Capecitabine and Oxaliplatin) in Previously Untreated Patients With Advanced Gastric Cancer

European Journal of Cancer
Cancer ResearchOncology
2015English

Capecitabine Plus Oxaliplatin Compared With 5-Fluorouracil Plus Oxaliplatin in Metastatic Colorectal Cancer: Meta-Analysis of Randomized Controlled Trials

Oncology Letters
Cancer ResearchOncology
2012English

Capecitabine and Oxaliplatin Versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients With Locally Advanced Rectal Carcinoma: A Comparative Study

Journal of Cancer Therapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy